LAMA4 and pancreatic adenocarcinoma: Additionally, high LAMA4, LAMB3 and LAMC2 expression groups were found to have a higher risk with regard to DFS in PAAD patients (HR=1.9, 1.7 and 1.8, respectively; Figure 1B).